Helix BioPharma Corp. Initiates Enrollment for Ninth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47

Marketwired
Helix BioPharma Corp. Initiates Enrollment for Ninth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47
Helix BioPharma Corp. Logo
View Comments (0)